Nel ASA (LON:0E4Q)
2.708
-0.018 (-0.66%)
At close: Oct 16, 2025
Nel ASA Revenue
Nel ASA had revenue of 173.92 million NOK in the quarter ending June 30, 2025, a decrease of -47.63%. This brings the company's revenue in the last twelve months to 1.11 billion, down -16.04% year-over-year. In the year 2024, Nel ASA had annual revenue of 1.39 billion with 2.97% growth.
Revenue (ttm)
1.11B NOK
Revenue Growth
-16.04%
P/S Ratio
4.61
Revenue / Employee
2.80M NOK
Employees
397
Market Cap
369.44M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.39B | 40.11M | 2.97% |
Dec 31, 2023 | 1.35B | 434.95M | 47.54% |
Dec 31, 2022 | 914.85M | 161.76M | 21.48% |
Dec 31, 2021 | 753.10M | 174.76M | 30.22% |
Dec 31, 2020 | 578.33M | 59.28M | 11.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 198.54B |
BP p.l.c. | 134.89B |
Unilever | 51.24B |
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Rio Tinto Group | 39.22B |
GSK plc | 31.63B |
BAE Systems | 27.41B |